FRANCESCO DE RUBERTIS
Co-founder and Partner, Medicxi
Francesco is a co-founder and Partner at Medicxi. Prior to Medicxi, Francesco was a Partner at Index Ventures for 19 years, having joined the firm in 1997 to launch its life sciences practice. Under his leadership, the asset-centric approach to life sciences investing was conceived and adopted. Francesco currently serves on the boards of a number of portfolio companies, including Palladio Biosciences, Rivus Pharmaceuticals, Orexia and Inexia.
Francesco’s prior investments include CellZome, GenMab, GenSight Biologics, Micromet, Minerva Neurosciences, Molecular Partners, PanGenetics, Parallele Biosciences, Profibrix and Versartis.
Francesco received a BA in Genetics and Microbiology from the University of Pavia and a PhD Molecular Biology from the University of Geneva. He conducted postdoctoral research at the Whitehead Institute at MIT and is a CFA Charterholder. Francesco also serves on the strategic advisory board of the University of Geneva.
LIVE ONLINE
17 November 2020
BOOK YOUR PLACE NOW